The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity
Open accessAbstract
Tumor-associated myeloid cells maintain immunosuppressive microenvironments within tumors. Identification of myeloid-specific receptors to modulate tumor-associated macrophage and myeloid-derived suppressor cell (MDSC) functions remains challenging. The leukocyte immunoglobulin-like receptor B (LILRB) family members are negative regulators of myeloid cell activation. We investigated how LILRB targeting could modulate tumor-associated myeloid cell function. LILRB2 antagonism inhibited receptor-mediated activation of SHP1/2 and enhanced proinflammatory responses. LILRB2 antagonism also inhibited AKT and STAT6 activation in the presence of M-CSF and IL-4. Transcriptome analysis revealed that LILRB2 antagonism altered genes involved in cell cytoskeleton remodeling, lipid/cholesterol metabolism, and endosomal sorting pathways, as well as changed differentiation gene networks associated with inflammatory myeloid cells as opposed to their alternatively activated phenotype. LILRB2 blockade effectively suppressed granulocytic MDSC and Treg infiltration and significantly promoted in vivo antitumor effects of T cell immune checkpoint inhibitors. Furthermore, LILRB2 blockade polarized tumor-infiltrating myeloid cells from non-small cell lung carcinoma tumor tissues toward an inflammatory phenotype. Our studies suggest that LILRB2 can potentially act as a myeloid immune checkpoint by reprogramming tumor-associated myeloid cells and provoking antitumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., & Udalova, I. A. (2011) · Nature Immunology · doi:10.1038/ni.1990 · Cited by 1,306
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283
PI3Kγ is a molecular switch that controls immune suppression
Kaneda, M. M., Messer, K. S., Ralainirina, N., Li, H., Leem, C. J., Gorjestani, S., Woo, G., Nguyen, A. V., Figueiredo, C. C., Foubert, P., et al. (2016) · Nature · doi:10.1038/nature19834 · Cited by 1,173
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
Chomarat, P., Banchereau, J., Davoust, J., & Karolina Palucka, A. (2000) · Nature Immunology · doi:10.1038/82763 · Cited by 906
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., & Hiraoka, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.32 · Cited by 849
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., et al. (2002) · Nature Immunology · doi:10.1038/ni760 · Cited by 800
Development and function of human innate immune cells in a humanized mouse model
Rongvaux, A., Willinger, T., Martinek, J., Strowig, T., Gearty, S. V., Teichmann, L. L., Saito, Y., Marches, F., Halene, S., Palucka, A. K., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2858 · Cited by 789 · cited 1×
“STEMCELL Technologies) as previously described (73).”
Resolution of inflammation: an integrated view
Ortega‐Gómez, A., Perretti, M., & Soehnlein, O. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202382 · Cited by 733
Discovering motifs in ranked lists of DNA sequences
Eden, E., Lipson, D., Yogev, S., & Yakhini, Z. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030039 · Cited by 696
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Bonapace, L., Coissieux, M.-M., Wyckoff, J., Mertz, K. D., Varga, Z., Junt, T., & Bentires-Alj, M. (2014) · Nature · doi:10.1038/nature13862 · Cited by 665
The TSC-mTOR pathway regulates macrophage polarization
Byles, V., Covarrubias, A. J., Ben-Sahra, I., Lamming, D. W., Sabatini, D. M., Manning, B. D., & Horng, T. (2013) · Nature Communications · doi:10.1038/ncomms3834 · Cited by 633
The interaction of anticancer therapies with tumor-associated macrophages
Mantovani, A., & Allavena, P. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150295 · Cited by 616
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E. D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119038109 · Cited by 608
CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects
Etzerodt, A., & Moestrup, S. K. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4834 · Cited by 604
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Lin, H., Wei, S., Hurt, E. M., Green, M. D., Zhao, L., Vatan, L., Szeliga, W., Herbst, R., Harms, P. W., Fecher, L. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96113 · Cited by 584
Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. J., Makadzange, A., Rowland-Jones, S., Willcox, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431057100 · Cited by 557
SOCS3, a Major Regulator of Infection and Inflammation
Carow, B., & Rottenberg, M. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00058 · Cited by 555 · cited 1×
“The induction of SOCS3 could result from the anti-LILRB2–mediated release of proinflammatory cytokines (IL-6 and IL-12) through activation of MAPK/NF-κB cascades (57, 58).”
Colonna, M., Samaridis, J., Cella, M., Ångman, L., Allen, R. L., O’Callaghan, C. A., Dunbar, P. R., Ogg, G. S., Cerundolo, V., & Rolink, A. G. (1998) · PubMed · Cited by 499
Colonna, M., Samaridis, J., Cella, M., Angman, L., Allen, R. L., O’Callaghan, C. A., Dunbar, R., Ogg, G. S., Cerundolo, V., & Rolink, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3096 · Cited by 457
Negative regulation of Toll-like-receptor signaling by IRF-4
Negishi, H., Ohba, Y., Yanai, H., Takaoka, A., Honma, K., Yui, K., Matsuyama, T., Taniguchi, T., & Honda, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508327102 · Cited by 405
Fleetwood, A. J., Dinh, H., Cook, A. D., Hertzog, P. J., & Hamilton, J. A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1108702 · Cited by 312
Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development
Zheng, J., Umikawa, M., Cui, C., Li, J., Chen, X., Zhang, C., Huynh, H., Kang, X., Silvany, R., Wan, X., et al. (2012) · Nature · doi:10.1038/nature11095 · Cited by 275
Self-citationSerotonin Skews Human Macrophage Polarization through HTR2B and HTR7
de las Casas-Engel, M., Domínguez-Soto, A., Sierra-Filardi, E., Bragado, R., Nieto, C., Puig-Kroger, A., Samaniego, R., Loza, M., Corcuera, M. T., Gómez-Aguado, F., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201133 · Cited by 251
IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II–Induced Muscle Wasting
Zhang, L., Du, J., Hu, Z., Han, G., Delafontaine, P., Garcia, G., & Mitch, W. E. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060628 · Cited by 240
Serial Analysis of Gene Expression in Human Monocytes and Macrophages
Hashimoto, S.-I., Suzuki, T., Dong, H.-Y., Yamazaki, N., & Matsushima, K. (1999) · Blood · doi:10.1182/blood.v94.3.837.413k02_837_844 · Cited by 232
Molecular Cloning and Characterization of a Novel Dual Specificity Phosphatase, MKP-5
Tanoue, T., Moriguchi, T., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19949 · Cited by 223
Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease
Zhao, G.-N., Jiang, D.-S., & Li, H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.030 · Cited by 212
Maeda, A., Kurosaki, M., Ono, M., Takai, T., & Kurosaki, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1355 · Cited by 203
Kang, K., Park, S. H., Chen, J., Qiao, Y., Giannopoulou, E., Berg, K., Hanidu, A., Li, J., Nabozny, G., Kang, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.017 · Cited by 196
Self-citationDC-SIGN+ Macrophages Control the Induction of Transplantation Tolerance
Conde, P., Rodriguez, M., van der Touw, W., Jimenez, A., Burns, M., Miller, J., Brahmachary, M., Chen, H.-M., Boros, P., Rausell-Palamos, F., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.009 · Cited by 187
Self-citationLi, H. Y., McSharry, M., Bullock, B., Nguyen, T. T., Kwak, J., Poczobutt, J. M., Sippel, T. R., Heasley, L. E., Weiser-Evans, M. C., Clambey, E. T., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0365 · Cited by 187
Ma, G., Pan, P.-Y., Eisenstein, S., Divino, C. M., Lowell, C. A., Takai, T., & Chen, S.-H. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.004 · Cited by 174
Self-citationMacrophage Colony-stimulating Factor Promotes Cell Survival through Akt/Protein Kinase B
Kelley, T. W., Graham, M. M., Doseff, A. I., Pomerantz, R. W., Lau, S. M., Ostrowski, M. C., Franke, T. F., & Marsh, C. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26393 · Cited by 171
Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice
Ujike, A., Takeda, K., Nakamura, A., Ebihara, S., Akiyama, K., & Takai, T. (2002) · Nature Immunology · doi:10.1038/ni801 · Cited by 170
Paired immunoglobulin‐like receptors and their MHC class I recognition
Takai, T. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02177.x · Cited by 167
LILRB receptor-mediated regulation of myeloid cell maturation and function
van der Touw, W., Chen, H.-M., Pan, P.-Y., & Chen, S.-H. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-2023-x · Cited by 167
Self-citationDomínguez‐Soto, Á., Sierra‐Filardi, E., Puig‐Kröger, A., Pérez-Maceda, B. T., Gómez, F., Corcuera, M. T., Sánchez‐Mateos, P., & Corbí, A. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000475 · Cited by 154
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Lin, H., Wei, S., Hurt, E. M., Green, M. D., Zhao, L., Vatan, L., Szeliga, W., Herbst, R., Harms, P. W., Fecher, L. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120803 · Cited by 149
HLA Class I Allelic Sequence and Conformation Regulate Leukocyte Ig-Like Receptor Binding
Jones, D. C., Kosmoliaptsis, V., Apps, R., Lapaque, N., Smith, I. A., Kono, A., Chang, C., Boyle, L. H., Taylor, C. J., Trowsdale, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003078 · Cited by 141
The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck
Li, J.-P., Yang, C.-Y., Chuang, H., Lan, J., Chen, D.-Y., Chen, Y., Wang, X., Chen, A. J., Belmont, J. W., & Tan, T. (2014) · Nature Communications · doi:10.1038/ncomms4618 · Cited by 140
Swierczak, A., Cook, A. D., Lenzo, J. C., Restall, C. M., Doherty, J. P., Anderson, R. L., & Hamilton, J. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0190 · Cited by 139
Interferon regulatory factor 7 participates in the M 1‐like microglial polarization switch
Tanaka, T., Murakami, K., Bandô, Y., & Yoshida, S. (2014) · Glia · doi:10.1002/glia.22770 · Cited by 133
Kang, S., Nakanishi, Y., Kioi, Y., Okuzaki, D., Kimura, T., Takamatsu, H., Koyama, S., Nojima, S., Nishide, M., Hayama, Y., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0108-0 · Cited by 130
Inhibitory Immunoglobulin-Like Receptors LILRB and PIR-B Negatively Regulate Osteoclast Development
Mori, Y., Tsuji, S., Inui, M., Sakamoto, Y., Endo, S., Ito, Y., Fujimura, S., Koga, T., Nakamura, A., Takayanagi, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4742 · Cited by 126
Rodríguez‐García, M., Porichis, F., de Jong, O. G., Levi, K., Diefenbach, T. J., Lifson, J. D., Freeman, G. J., Walker, B. D., Kaufmann, D., & Kavanagh, D. G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610327 · Cited by 111
Protein tyrosine phosphatases as wardens of STAT signaling
Böhmer, F., & Friedrich, K. (2014) · JAK-STAT · doi:10.4161/jkst.28087 · Cited by 110
Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B
Ho, L. H., Uehara, T., Chen, C., Kubagawa, H., & Cooper, M. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15086 · Cited by 110
Lichterfeld, M. D., Kavanagh, D. G., Williams, K. L., Jalali, B. M., Mui, S. K., Miura, T., Sivamurthy, R., Allgaier, R. L., Pereyra, F., Piechocka‐Trocha, A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061865 · Cited by 107
Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma
Zaki, M. A. A., Wada, N., Ikeda, J., Shibayama, H., Hashimoto, K., Yamagami, T., Tatsumi, Y., Tsukaguchi, M., Take, H., Tsudo, M., et al. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1140-8 · Cited by 87
Hashimoto, S., Yamada, M., Motoyoshi, K., & Akagawa, K. S. (1997) · Blood · doi:10.1182/blood.v89.1.315 · Cited by 84
The role of SHIP1 in macrophage programming and activation
Rauh, M. J., Sly, L. M., Kalesnikoff, J., Hughes, M. R., Cao, L., Lam, V., & Krystal, G. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320785 · Cited by 75
Smith, J. L., Schaffner, A. E., Hofmeister, J. K., Hartman, M. S., Guo, W., Forsthoefel, D. J., Hume, D. A., & Ostrowski, M. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8026-8034.2000 · Cited by 71
Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k)
Cheng, H., Mohammed, F., Nam, G., Chen, Y., Qi, J., Garner, L. I., Allen, R. L., Yan, J., Willcox, B. E., & Gao, G. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221028 · Cited by 62
Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells
Endo, S., Sakamoto, Y., Kobayashi, E., Nakamura, A., & Takai, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804571105 · Cited by 57
Munitz, A., Cole, E. T., Beichler, A., Groschwitz, K. R., Ahrens, R., Steinbrecher, K. A., Willson, T. A., Han, X., Denson, L. A., Rothenberg, M. E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.006 · Cited by 56
Hebenstreit, D., Luft, P., Schmiedlechner, A., Duschl, A., & Horejs-Hoeck, J. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.004 · Cited by 55
Blanchette, J., Abu‐Dayyeh, I., Hassani, K., Whitcombe, L. A., & Olivier, M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02929.x · Cited by 50
Zhang, J., Mai, S., Chen, H., Kang, K., Li, X. C., Chen, S., & Pan, P. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr1216-534r · Cited by 48
Self-citationBanchereau, J., Zurawski, S., Thompson-Snipes, L., Blanck, J.-P., Clayton, S., Munk, A., Cao, Y., Wang, Z., Khandelwal, S., Hu, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205785109 · Cited by 47
The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains
Zhang, Z., Hatano, H., Shaw, J. M., Nordkamp, M. O., Jiang, G., Li, D., & Kollnberger, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129063 · Cited by 44
SOCS3 is a modulator of human macrophage phagocytosis
Gordon, P., Okai, B., Hoare, J. I., Erwig, L. P., & Wilson, H. M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1215-554rr · Cited by 43
Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair
Bashirova, A. A., Apps, R., Vince, N., Mochalova, Y., Yu, X. G., & Carrington, M. N. (2013) · Immunogenetics · doi:10.1007/s00251-013-0730-9 · Cited by 41
Interaction between HLA-G and monocyte/macrophages in human pregnancy
Shakhawat, A., Shaikly, V., Elzatma, E., Mavrakos, E., Asma, J., & Fernández, N. (2010) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.02.004 · Cited by 39
White, C., & Nicola, N. (2013) · JAK-STAT · doi:10.4161/jkst.25045 · Cited by 39
Nakata, K., Suzuki, Y., Inoué, T., Ra, C., Yakura, H., & Mizuno, K. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.10.001 · Cited by 30
Induction of Sphk1 activity in obese adipose tissue macrophages promotes survival
Gabriel, T. L., Mirzaian, M., Hooibrink, B., Ottenhoff, R., van Roomen, C. P. A. A., Aerts, J. M. F. G., & van Eijk, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182075 · Cited by 25
Cloning of rhesus monkey LILRs*
Slukvin, I. I., Grendell, R. L., Rao, D. S., Hughes, A. L., & Golos, T. G. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00579.x · Cited by 15
TORching a semaphore for alternative macrophage activation
Wilson, J. L., & Weichhart, T. (2018) · Nature Immunology · doi:10.1038/s41590-018-0117-z · Cited by 4
Cited by
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
“Studies found that LILRB2 blockade by LILRB2-specific monoclonal antibodies effectively polarized macrophage cells toward an inflammatory phenotype and enhanced pro-inflammatory responses, thus acting as a myeloid immune checkpoint by reprogramming TAMs and provoking antitumor immunity [171, 172].”
BackgroundNeutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
Klemm, F., Maas, R. R., Bowman, R. L., Kornete, M., Soukup, K., Nassiri, S., Brouland, J.-P., Iacobuzio-Donahue, C. A., Brennan, C., Tabar, V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.007 · Cited by 1,037
Phagocytosis checkpoints as new targets for cancer immunotherapy
Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y.-X., & Weissman, I. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0183-z · Cited by 911
Metadata
- Authors
- Chen, H.-M., van der Touw, W., Wang, Y. S., Kang, K., Mai, S., Zhang, J., Alsina-Beauchamp, D., Duty, J. A., Mungamuri, S. K., Zhang, B., Moran, T., Flavell, R., Aaronson, S., Hu, H.-M., Arase, H., Ramanathan, S., Flores, R., Pan, P.-Y., & Chen, S.-H.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-10-22
- Volume
- 128
- Issue
- 12
- Pages
- 5647-5662
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2897898885
- Cited by
- 253
- References
- 75
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.